Minimally Invasive Urinary Incontinence Device Market Demand Forecast and Leading Players Analysis Through 2029

on

Minimally Invasive Urinary Incontinence Device Market

 Get 20% Off Market Intelligence Reports With Code ONLINE20 – Track Global Tariffs, Economic Shifts, and Sector Transformations


What Is the Potential Market Growth Rate of the Minimally Invasive Urinary Incontinence Device Market?
The minimally invasive urinary incontinence device market size has grown strongly in recent years. It will grow from $1.15 billion in 2024 to $1.25 billion in 2025 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to growing awareness about urinary incontinence treatment options, increasing availability of minimally invasive procedures, a rising number of aging people requiring bladder control solutions, the introduction of new sling and bulking agent systems, and improvements in surgical training for incontinence management.

The minimally invasive urinary incontinence device market size is expected to see strong growth in the next few years. It will grow to $1.76 billion in 2029 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to expanding reimbursement support for minimally invasive urinary treatments, growing demand for outpatient and same-day procedures, rising focus on patient comfort and quicker recovery, increasing adoption in emerging economies, and rising incidence of incontinence due to lifestyle and medical conditions. Major trends in the forecast period include continuous innovation in device miniaturization and material safety, integration of wireless monitoring and control features, research and development in nerve stimulation technologies, advancements in adjustable and reusable sling systems, and adoption of 3D printing for customized urinary devices.

Claim your free report sample now:

What Are the Most Significant Drivers Affecting the Minimally Invasive Urinary Incontinence Device Market Expansion?
The growing incidence of prostate cancer is expected to propel the growth of the minimally invasive urinary incontinence device market going forward. Prostate cancer is the uncontrolled growth of cells in the prostate gland that can impact urinary and reproductive health. The rising incidence of prostate cancer is largely driven by an aging male population, as older age is a significant risk factor for the disease. Minimally invasive urinary incontinence devices help manage prostate cancer-related urinary complications by providing targeted support to control bladder leakage, restore normal urinary function, and significantly improve the overall quality of life for patients undergoing treatment or recovery. For instance, in June 2025, according to the Centers for Disease Control and Prevention, a US-based government agency, in the United States, an estimated 255,395 new cases of prostate cancer were diagnosed in 2022, and in 2023, the disease was responsible for the deaths of approximately 33,881 men. Therefore, the growing incidence of prostate cancer is driving the growth of the minimally invasive urinary incontinence device market.

Which Segment Holds the Largest Share in the Minimally Invasive Urinary Incontinence Device Market?
The minimally invasive urinary incontinence device market covered in this report is segmented

1) By Type: Tension Free Vaginal Tape (TVT), Tension Free Vaginal Tape (TVT) Obturator System, Other Types
2) By Age Group: Adults (18-65 years), Senior Population (65 Years And Above), Pediatric Population
3) By End-User: Hospitals, Clinics, Home Healthcare Settings, Research Institutions

Subsegments:
1) By Tension Free Vaginal Tape (TVT): Mid Urethral Sling, Retropubic Sling, Single Incision Sling
2) By Tension Free Vaginal Tape Obturator System (TVTO): Inside Out Approach, Outside In Approach
3) By Other Types: Bulking Agents, Artificial Urinary Sphincter, Sling Systems

Which Trends Are Positively Affecting the Minimally Invasive Urinary Incontinence Device Market Expansion?
Major companies operating in the minimally invasive urinary incontinence device market are focusing on developing advanced products such as neuromodulation therapy devices to offer effective long-term solutions with minimal surgical intervention. Neuromodulation therapy devices are implants that activate bladder-controlling nerves to regulate urinary function and help manage incontinence by enhancing bladder control and reducing accidental leakage. For instance, in December 2023, BlueWind Medical Ltd., a US-based company that manufactures neurostimulation devices, launched its Revi implantable tibial neuromodulation (iTNM) device. It is a battery-free, minimally invasive implant designed to treat urge urinary incontinence (UUI) by stimulating the posterior tibial nerve. The device is implanted near the ankle during a single outpatient procedure under local anesthesia and is activated using a lightweight wearable, allowing patients to manage symptoms conveniently at home. This launch reflects the ongoing trend of introducing innovative, patient-friendly neuromodulation solutions in the urinary incontinence device market.

Which Companies Are Driving Innovation in the Minimally Invasive Urinary Incontinence Device Market?
Major companies operating in the minimally invasive urinary incontinence device market are Johnson & Johnson Services Inc., Medtronic plc, Becton Dickinson and Company, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Coloplast A/S, Teleflex Incorporated, Hollister Incorporated, CooperSurgical Inc., B. Braun Melsungen Aktiengesellschaft, LiNA Medical ApS, BlueWind Medical Ltd., Caldera Medical Inc., Neuspera Medical Inc., InControl Medical LLC, UroMems Inc., Rigicon Inc., Valencia Technologies Corporation, Zephyr Surgical Implants SA.

Get the full minimally invasive urinary incontinence device market report here:

How Is the Competitive Landscape Varying Across Different Regions in the Minimally Invasive Urinary Incontinence Device Market?
North America was the largest region in the minimally invasive urinary incontinence device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the minimally invasive urinary incontinence device market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:

The Business Research Company


Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267



Follow Us On:

Comments

Post a Comment